Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China
· Delayed Price · Currency is CNY 16.63
-0.19 (-1.13%)
At close: Mar 9, 2026
SHA:603456 Revenue
Zhejiang Jiuzhou Pharmaceutical had revenue of 1.29B CNY in the quarter ending September 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to 5.36B, up 9.03% year-over-year. In the year 2024, Zhejiang Jiuzhou Pharmaceutical had annual revenue of 5.16B, down -6.57%.
Revenue (ttm)
5.36B
Revenue Growth
+9.03%
P/S Ratio
2.74
Revenue / Employee
1.07M
Employees
5,001
Market Cap
14.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.16B | -362.83M | -6.57% |
| Dec 31, 2023 | 5.52B | 78.31M | 1.44% |
| Dec 31, 2022 | 5.45B | 1.38B | 34.01% |
| Dec 31, 2021 | 4.06B | 1.42B | 53.48% |
| Dec 31, 2020 | 2.65B | 630.47M | 31.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guobang Pharma | 5.94B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Hybio Pharmaceutical | 898.10M |
| Shenzhen Hepalink Pharmaceutical Group | 5.38B |
| Guangdong Zhongsheng Pharmaceutical | 2.45B |
| ApicHope Pharmaceutical Group | 1.02B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 4.24B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |